Chemoprevention of carcinogenesis by organoselenium compounds

Journal of Health Science

Volumn 46, Issue 6, 2000, Pages 422-425

  Sugie, Shigeyuki ^a   Tanaka, Takuji ^b   El Bayoumy, Karam ^c  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KANAZAWA MEDICAL UNIVERSITY   (Japan)

^c AMERICAN HEALTH FOUNDATION   (United States)

Author keywords

Animal model; Carcinogenesis; Chemoprevention; Organoselenium compound

Indexed keywords

1,4 PHENYLENEBIS(METHYLENE)SELENOCYANATE; 4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; 4 METHOXYBENZENESELENOL; 4 NITROQUINOLINE 1 OXIDE; 7 METHYLGUANINE; AZOXYMETHANE; BENZO[A]PYRENE; BENZYLSELENOCYANATE; CYTOCHROME P450; DIMETHYLBENZ[A]ANTHRACENE; GLUTATHIONE PEROXIDASE; METHYLGUANIDINE; ORGANOSELENIUM DERIVATIVE; SELENIUM DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL MODEL; APOPTOSIS; BREAST TUMOR; CANCER; CANCER CHEMOTHERAPY; CARCINOGENESIS; COLON TUMOR; DNA ADDUCT; DNA ALKYLATION; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME ASSAY; HYDROXYLATION; KIDNEY TUMOR; LIVER TUMOR; LUNG INJURY; LUNG TUMOR; NONHUMAN; OXIDATION; SHORT SURVEY; STOMACH TUMOR;

EID: 0034536774     PISSN: 13449702     EISSN: None     Source Type: Journal    
DOI: 10.1248/jhs.46.422     Document Type: Short Survey

References (28)